Proximal Xq28 duplication syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1762OMIM:300815Q99.8
Who is this for?
Show terms as
1Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Proximal Xq28 duplication syndrome (also known as Xq28 duplication syndrome or int22h1/int22h2-mediated Xq28 duplication syndrome) is a rare X-linked chromosomal disorder caused by a recurrent duplication in the proximal portion of the Xq28 region of the X chromosome. This duplication typically encompasses several genes, and the clinical presentation predominantly affects males, while carrier females are usually asymptomatic or mildly affected. The condition primarily impacts the neurological system, with affected individuals commonly presenting with intellectual disability ranging from mild to severe, developmental delay (particularly speech and language delay), and behavioral abnormalities. Recurrent infections, especially respiratory infections, are frequently observed and are thought to be related to immune dysregulation. Key clinical features include hypotonia (low muscle tone) in infancy, seizures or epilepsy, feeding difficulties in early life, and distinctive facial features that may include a long face, prominent forehead, and midface hypoplasia. Growth abnormalities and gastrointestinal problems such as gastroesophageal reflux and constipation may also be present. Some patients develop spasticity in the lower limbs over time. The severity of symptoms can vary considerably among affected individuals, even within the same family. There is currently no cure or specific targeted therapy for proximal Xq28 duplication syndrome. Management is supportive and symptomatic, involving a multidisciplinary team approach. This may include physical therapy, occupational therapy, speech therapy, antiepileptic medications for seizure control, and proactive management of recurrent infections. Early intervention programs and individualized educational support are important components of care. Genetic counseling is recommended for affected families to understand recurrence risks and carrier status.

Also known as:

Clinical phenotype terms— hover any for plain English:

Hernia of the abdominal wallHP:0004299Tented upper lip vermilionHP:0010804
Inheritance

X-linked recessive

Carried on the X chromosome; typically affects males more than females

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

1 event
Oct 2024A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)

HuidaGene Therapeutics Co., Ltd. — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Proximal Xq28 duplication syndrome.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
N/A1 trial
A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR RNA-editing Therapy in Patients with Mecp2 Duplication Syndrome, a Rare Orphan Disease (HERO)
N/A
Actively Recruiting
PI: Study Director · Sites: Beijing, Beijing Municipality · Age: 218 yrs

No specialists are currently listed for Proximal Xq28 duplication syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
⚗️ Trial Site

Peking University First Hospital

📍 Beijing, Beijing Municipality

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

Travel Grants

No travel grants are currently matched to Proximal Xq28 duplication syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Proximal Xq28 duplication syndromeForum →

No community posts yet. Be the first to share your experience with Proximal Xq28 duplication syndrome.

Start the conversation →

Latest news about Proximal Xq28 duplication syndrome

Disease timeline:

New trial: A First-in-Human Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of a Novel CRISPR

Phase NA trial recruiting. HG204

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Proximal Xq28 duplication syndrome

What is Proximal Xq28 duplication syndrome?

Proximal Xq28 duplication syndrome (also known as Xq28 duplication syndrome or int22h1/int22h2-mediated Xq28 duplication syndrome) is a rare X-linked chromosomal disorder caused by a recurrent duplication in the proximal portion of the Xq28 region of the X chromosome. This duplication typically encompasses several genes, and the clinical presentation predominantly affects males, while carrier females are usually asymptomatic or mildly affected. The condition primarily impacts the neurological system, with affected individuals commonly presenting with intellectual disability ranging from mild t

How is Proximal Xq28 duplication syndrome inherited?

Proximal Xq28 duplication syndrome follows a x-linked recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Proximal Xq28 duplication syndrome typically begin?

Typical onset of Proximal Xq28 duplication syndrome is infantile. Age of onset can vary across affected individuals.

Are there clinical trials for Proximal Xq28 duplication syndrome?

Yes — 1 recruiting clinical trial is currently listed for Proximal Xq28 duplication syndrome on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.